Imperial College London

Emeritus ProfessorTimothyWilliams

Faculty of MedicineNational Heart & Lung Institute

Emeritus Professor in Airway Disease



+44 (0)20 7594 3159tim.williams Website




Office no. 360Sir Alexander Fleming BuildingSouth Kensington Campus




Guest Lectures

Selective suppression of leukocyte recruitment in allergic inflammation, Mucosal Inflammation Research Group, Rio de Janerio, Brazil, 2004

Targeting inflammatory cells in allergic diseases, 125. British Pharmacological Society, Summer Meeting - Spotlight on Therapeutic Targets in Inflammation, 2004

Keystone Symposium, Chemokines and chemokine receptors, Breckonridge, Colorado, USA, 2003

Chemokines roles in immunoregulation and disease, Ernst Schering Research Foundation, Nappa Valley, Califofrnia, USA, 2002

Eosinohil Trafficking, British Association for Lung Research Summer Meeting, Dublin, Ireland, 2002

Chemokines in Asthma and Allergy: Towards the Holy Grail of Selective Therapy?, IRA Chemokine Conference, Cambridge MA USA., 2001

Chemokines in eosinophil recruitment in asthma, Fifth FASEB on Cytokines and Lipid Mediators, Vermont. Canada, 2001

Eosinophil 2001 International Symposium, Banff, Alberta, Canada, 2001

Keystone Symposium on chemokines and chemokine receptors, Taos, New Mexico, 2001

Discovery of Eotaxin: a Novel Therapeutic Target for Asthma and Allergy, The Gaddum Memorial Lecture 2000 at the BPS WInter Meeting, 2000

Chemokines in chronic allergic inflammation: opportunities for novel therapeutic intervention, American Academy of Allergy, Asthma and Immunology, San Diego, California, USA, 2000

Chemokines in mobilisation of eosinophils, 1st International Conference on Immunopharmacology of Bronchial Asthma, Taipei, Taiwan, 1999

Role of Eotaxin and related chemokines in asthma and allergy, Keystone Symposium on Molecular and Cellular Biology, Keystone, Colorada, USA, 1999

The role of Eotaxin in the transfer of eosinophils from the bone marrow to the asthmatic lung., Inflammation Research Association 9th International Conference, Hershey Lodge, Hershey, PA. USA. Opening Keynote Plenary Speaker, 1998

Regulation of Eotaxin, Cold Spring Harbor Symposium, The Molecular Basis of Asthma: Fundamental Processes with Potential Genetic and Therapeutic Targets. Banbury Centre, Cincinnati, USA, 1998

Eotaxin and eosinophil traffick in vivo, FASEB Summer Conference, Vermont, USA, 1997

Eosinophilic inflammation, repair and fibrosis, 8th Nikolas Symposia, Athens, Greece, 1997

Eotaxin, Keystone Symposium on Molecular & Cellular Biology, Copper Mountain, Colorado, USA, 1997

Interactions between IL-5 and Eotaxin, IL-5 Conference, Perth, Western Australia, 1996

Chemokines in disease, Gordon Conference on Chemotactic Cytokines, Holderness School, Plymouth, New Hampshire, USA, 1996

Asthma: Possible causes and successful management., Queen Elizabeth 11 Conferene Centre, Westminster, London, UK, 1995

Eosinophil chemoattractants generated in allergic reactions., 2nd IAIS World Congress on Inflammation, Brighton, Sussex, 1995

Eotaxin - Chairman and Speaker, Forth Internation Chemokine Symposium, Bath University, Bath, Avon, 1995

Mechanisms of eosinophil recruitment in animal model of allergic inflammation, American Academy of Allergy and Immunology, New York, USA, 1995

Eosinophil chemoattractants generated in vivo, IUPHAR Satellite Meeting, Toronto, CANADA, 1994

Effects of nitric oxide on the microcirculation in vivo, First IAIS World Congress on Inflammation'93, Vienna, Austria, 1993

The microcirculation in inflammation, BPS Australasia Visitor 1992. University of NSW, Sydney, Australia, 1992

Neutrophils at sites of inflammation: How do they get there?, Guest Lecture, Royal Academy of Medicine, Dublin, Ireland, 1992

Granulocyte-dependent and independent mechanisms in inflammation, Second Jacques Monod Conference on Blood Vessels, Aussois, France., 1991

In vivo models of inflammation, NATO Advanced Study Institute on Vascular Endothelium, Corfu, Greece., 1990